Why the study?
Does concurrent use of cranberry juice destabilize warfarin therapy in patients receiving anticoagulation?
Does concurrent use of cranberry juice destabilize warfarin therapy in patients receiving anticoagulation?
Clinicians should be aware that large volumes of cranberry juice can destabilize warfarin therapy and should monitor and counsel patients accordingly.
Answers are grounded in this paper and cite their sources.
Large cranberry juice volumes warrant caution with warfarin; leaves open the interaction magnitude pending prospective confirmation.
Warfarin is extensively used for anticoagulation to a target international normalized ratio of 2.0-3.0 for most indications or 2.5-3.5 for high-risk indications; however, many drugs and dietary supplements induce fluctuations in the international normalized ratio. Such fluctuations may lead to therapeutic failure or bleeding complications. Cranberry juice is increasingly used for the prevention and adjunctive treatment of urinary tract infections. The United Kingdom's Committee on Safety of Medicines has alerted clinicians to a potential interaction between warfarin and cranberry juice and has advised that patients avoid their concurrent use. Review and analysis of the literature revealed that ingestion of large volumes of cranberry juice destabilize warfarin therapy. Small amounts of juice are not expected to cause such an interaction. Clinicians should be aware of this potential interaction and monitor and counsel patients accordingly.
No takes yet. Share an insight, caveat, or question.
Aston et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: